Evidence map›Paper›PMID 29435274›Full record

ArticleBiomedical reports2018

Topical 5% potassium permanganate solution accelerates the healing process in chronic diabetic foot ulcers.

Iván Delgado-Enciso, Violeta M Madrigal-Perez, Agustin Lara-Esqueda, Martha G Diaz-Sanchez, Jose Guzman-Esquivel, Luis E Rosas-Vizcaino, Oscar O Virgen-Jimenez, Juleny Kleiman-Trujillo, Maria R Lagarda-Canales, Gabriel Ceja-Espiritu and 5 more

Abstract read
In one paragraph

Article in Biomedical reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Iván Delgado-EncisoDepartment of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Violeta M Madrigal-PerezDepartment of Public Health, School of Medicine, University of Colima, Las Víboras, Colima 28040, Mexico.
Agustin Lara-EsquedaDepartment of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Martha G Diaz-SanchezDepartment of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Jose Guzman-EsquivelDepartment of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Luis E Rosas-VizcainoDepartment of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Oscar O Virgen-JimenezDepartment of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Juleny Kleiman-TrujilloDepartment of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Maria R Lagarda-CanalesDepartment of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Gabriel Ceja-EspirituDepartment of Public Health, School of Medicine, University of Colima, Las Víboras, Colima 28040, Mexico.
Viridiana Rangel-SalgadoDepartment of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Uriel A Lopez-LemusDepartment of Public Health, School of Medicine, University of Colima, Las Víboras, Colima 28040, Mexico.
Josuel Delgado-EncisoDepartment of Research, Foundation for Cancer Ethics, Education and Research of the Cancerology State Institute, Colima 28085, Mexico.
Agustin D Lara-BasultoDepartment of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Alejandro D Soriano HernándezDepartment of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Potassium permanganate has been reported to be an effective treatment for certain types of wounds. The aim of the present study was to evaluate the use of potassium permanganate in the treatment of diabetic foot ulcers. A single-blind, randomized, controlled clinical trial was conducted on patients with type 2 diabetes mellitus that presented with a foot ulcer persisting for >3 months. The control group (n=10) was treated with the current standard treatment, which comprises of measures for reducing pressure in the ulcerated area, daily cleansing of the ulcer with potable water and antiseptic wash solution, and the application of a disinfectant solution on the entire surface area of the ulcer; while the intervention group (n=15) received the standard treatment plus 5% topical potassium permanganate solution applied once a day for 21 days. In the intervention group, 1 patient did not tolerate the treatment and was eliminated from the study on the first day. The remaining patients tolerated the interventions well. At the end of the treatment period, ulcers in the control group had decreased by 38% whereas those in the intervention group decreased by 73% (P<0.009). The degree of decrease was also investigated; the ulcer size was ≥50% decreased in 40% of patients in the control group and in 86% of patients in the intervention group (P=0.02). In conclusion, the results of the present study indicate that topical potassium permanganate is well tolerated and significantly accelerates the healing process of diabetic foot ulcers.

Indexed as

diabetesdiabetic footMexicopotassium permanganatetreatment

Identifiers

PMID29435274
PMCPMC5778841

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.